High- to intermediate pathogenicity variants in LAMA2, MYBPC3, MYH6, KCNQ1, GAA, and DSG2 predominated in CHD VT patients at similar frequencies as those observed for DCM VT and iVT patients. This evidence concerns the gene MYBPC3 and coronary artery disorder.